Skip to main content
Top
Published in: Intensive Care Medicine 7/2011

01-07-2011 | Correspondence

Drug-induced hepatic cholestasis in the critically ill

Authors: Anne Julie Frenette, Marie-Eve Bédard Dufresne, Valérie Bonhomme, Martin Albert, David R. Williamson

Published in: Intensive Care Medicine | Issue 7/2011

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A (2009) The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab 94:2345–2352PubMedCrossRef Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A (2009) The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab 94:2345–2352PubMedCrossRef
2.
go back to reference Boland GW, Slater G, Lu DS, Eisenberg P, Lee MJ, Mueller PR (2000) Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol 174:973–977PubMed Boland GW, Slater G, Lu DS, Eisenberg P, Lee MJ, Mueller PR (2000) Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol 174:973–977PubMed
3.
go back to reference Grau T, Bonet A, Rubio M, Mateo D, Farre M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A (2007) Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 11:R10PubMedCrossRef Grau T, Bonet A, Rubio M, Mateo D, Farre M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A (2007) Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 11:R10PubMedCrossRef
5.
go back to reference Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41:816–819PubMedCrossRef Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41:816–819PubMedCrossRef
Metadata
Title
Drug-induced hepatic cholestasis in the critically ill
Authors
Anne Julie Frenette
Marie-Eve Bédard Dufresne
Valérie Bonhomme
Martin Albert
David R. Williamson
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 7/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2188-2

Other articles of this Issue 7/2011

Intensive Care Medicine 7/2011 Go to the issue